Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 10,136.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,136.22% |
Kindly MD, Inc Warrants (KDLYW) | 9,775% |
DeFi Development (DFDV) | 3,197.67% |
Protagenic Therapeutics (PTIXW) | 2,023.08% |
HCM II Acquisition (HONDW) | 1,968.97% |
Kindly MD, Inc Common Stock (KDLY) | 1,854.03% |
Mobile Global Esports (MGAM) | 1,425% |
Diginex Limited Ordinary Shares (DGNX) | 1,343.66% |
Asset Entities Inc Class B Common Stock (ASST) | 1,328% |
Oncology Institute (TOI) | 919.61% |
TMC the metals company Inc Warrants (TMCWW) | 871.7% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 738.57% |
Oncology Institute (TOIIW) | 707.14% |
Webull Corporation Warrants (BULLW) | 616.39% |
Abits (ABTS) | 539.5% |
Siyata Mobile (SYTAW) | 528.89% |
Dave Inc Warrants (DAVEW) | 496.5% |
Edible Garden (EDBLW) | 480.28% |
DatChat Inc Series A Warrant (DATSW) | 465.22% |
Top KingWin (WAI) | 452.63% |
Nutex Health (NUTX) | 416.7% |
VivoPower International (VVPR) | 404.44% |
ThredUp (TDUP) | 401.39% |
Dominari (DOMH) | 401.22% |
Regulus Therapeutics (RGLS) | 395.63% |
